Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Crizanlizumab in Patients with Sickle Cell Disease: Final Interim Analysis Results from the Phase 2 Solace-Adults StudyJulie Kanter,Sarah Mennito,Santosh M. Nair,Deepa Manwani,Abdullah Kutlar,Nirmish Shah,Deborah Keefe, Hariprasad Madhamshetty, Evgeniya Reshetnyak, Anisha E. Mendonza,Darla K. LilesBLOOD（2023）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
